Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TIGECYCLINE Cause Disseminated intravascular coagulation? 9 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Disseminated intravascular coagulation have been filed in association with TIGECYCLINE (Tigecycline). This represents 0.3% of all adverse event reports for TIGECYCLINE.

9
Reports of Disseminated intravascular coagulation with TIGECYCLINE
0.3%
of all TIGECYCLINE reports
7
Deaths
4
Hospitalizations

How Dangerous Is Disseminated intravascular coagulation From TIGECYCLINE?

Of the 9 reports, 7 (77.8%) resulted in death, 4 (44.4%) required hospitalization, and 7 (77.8%) were considered life-threatening.

Is Disseminated intravascular coagulation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TIGECYCLINE. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does TIGECYCLINE Cause?

Drug ineffective (486) Off label use (473) Nausea (257) Vomiting (174) Coagulopathy (173) Thrombocytopenia (150) Drug resistance (148) Sepsis (123) Pathogen resistance (122) Death (121)

What Other Drugs Cause Disseminated intravascular coagulation?

PREDNISOLONE (362) METHOTREXATE (347) DEXAMETHASONE (323) METHYLPREDNISOLONE (307) NIVOLUMAB (305) CYCLOPHOSPHAMIDE (286) TACROLIMUS (278) PREDNISONE (277) VINCRISTINE (245) OXALIPLATIN (231)

Which TIGECYCLINE Alternatives Have Lower Disseminated intravascular coagulation Risk?

TIGECYCLINE vs TIKOSYN TIGECYCLINE vs TILDRAKIZUMAB TIGECYCLINE vs TILDRAKIZUMAB-ASMN TIGECYCLINE vs TILIDINE TIGECYCLINE vs TIMOLOL

Related Pages

TIGECYCLINE Full Profile All Disseminated intravascular coagulation Reports All Drugs Causing Disseminated intravascular coagulation TIGECYCLINE Demographics